Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva

Rational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast Cancer

Mark D. Pegram, G. Konecny, Christopher J. O’Callaghan et al. · JNCI Journal of the National Cancer Institute · 2004 · 509 citations

Medicine, Oncology, Pharmacology +16

Metastatic extramammary Paget’s disease treated with paclitaxel and trastuzumab combination chemotherapy

Shunsuke Takahagi, Hideki Noda, Akiko Kamegashira et al. · The Journal of Dermatology · 2009 · 105 citations

Medicine, Oncology, Pharmacology +17

HER-2/neu targeting for recurrent vulvar Paget's disease

Amer Karam, Jonathan S. Berek, Amy Stenson et al. · Gynecologic Oncology · 2008 · 77 citations

Medicine, Gynecology, Oncology +12

A Case of Metastatic Extramammary Paget’s Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy

Fumie Hanawa, Takashi Inozume, Kazutoshi Harada et al. · Case Reports in Dermatology · 2011 · 73 citations · Full text

Medicine, Oncology, Pathology +17

HER2 molecular subtype is a dominant subtype of mammary Paget’s cells. An immunohistochemical study

Piotr Sęk, Antoni Żawrocki, Wojciech Biernat et al. · Histopathology · 2010 · 53 citations · Full text

Medicine, Oncology, Pathology +17